col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


104 Results       Page 1

 [1] 
Springer (Biomed Central Ltd.): Journal of Pharmaceutical Policy and Practice
  original article Date Title Authors   All Authors
1 [GO] 2025―Feb―05 The prevalence of thromboembolic events among COVID-19 patients admitted to a single centre intensive care unit (ICU): an epidemiological study from a Malaysian population Nur Farhani Mansor, Izzati Abdul Halim Zaki, Lee Chew Kiok, Eng Kar Seng, Tharmini Ravi, Mohan Pathmanathan, et al. (+4)
2 [GO] 2025―Jan―28 How does the medicines retail sector ensure continued access to medicines during public health emergencies? Lessons from the COVID-19 pandemic in Uganda Eleanor Hutchinson, Sunday Mundua, Jessica Myers, Sian E. Clarke, Kristian Schultz Hansen, Chrispus Mayora, et al. (+2)
3 [GO] 2024―Oct―29 A quantitative investigation in a territory of Italy on citizens’ attitudes towards medicines through the COVID-19 pandemic: the importance of possible indirect effects caused by the pandemic Antonio Mastino, Francesca Pettinau, Piergiorgio Palla, Giuseppina Ozzella, Massimiliano Grosso, Barbara Pittau
4 [GO] 2024―Sep―25 Trends in medicine utilisation in public and private healthcare facilities before and during COVID-19: a nationwide analysis of medicine procurement and sales data, 2018-2022 Norazida Ab Rahman, Ee Vien Low, Audrey Huili Lim, Azzy Iyzati Ahmad Shanizza, See Wan Ho, Mardhiyah Kamal, et al. (+2)
5 [GO] 2024―Jul―12 The pharmacists’ interventions after a Drug and Therapeutics Committee (DTC) establishment during the COVID-19 pandemic Amira B. Kassem, Ahmad Z. Al Meslamani, Dina H. Elmaghraby, Yosr Magdy, Mohamed AbdElrahman, Ahmed M.E. Hamdan, Hebatallah Ahmed Mohamed Moustafa
6 [GO] 2024―Apr―17 Methylprednisolone use in hospitalised COVID-19 patients: a retrospective study Nur Fatin Najwa Azemi, Farida Islahudin, Rahela Ambaras Khan, Shamin Mohd Saffian, Leong Chee Loon
7 [GO] 2024―Mar―14 Odds and associated factors for thrombosis development among Lebanese COVID-19 patients: a case-control retrospective study Mahmoud Youness, Sara Mansour, Fouad Sakr, Samer Olabi, Sarah Atwi, Iman Younes Martinez, et al. (+5)
8 [GO] 2024―Feb―27 Self-reported side effects of COVID-19 vaccines among the public Mahmathi Karuppannan, Long Chiau Ming, Mohd Shahezwan Abdul Wahab, Zakiah Mohd Noordin, Shermaine Yee, Andi Hermansyah
9 [GO] 2024―Jan―21 A qualitative study exploring community pharmacists’ awareness, attitudes and perceptions about drive-thru community pharmacy service in Malaysia during COVID-19 Bayan F. Ababneh, Siew Chin Ong, Iffat Elbarazi, Hisham Z. Aljamal, Rabia Hussain
10 [GO] 2024―Jan―03 Healthcare commissioners’ experience with antibiotic resistance during the COVID-19 pandemic in Saudi Arabia: a qualitative study Hadi Jaber Al Sulayyim, Rohani Ismail, Abdullah Al Hamid, Noraini Abdul Ghafar
11 [GO] 2024―Jan―03 Psychological dynamics of pandemic resilience: a tale of two cultures Shazia Rehman, Erum Rehman, Akhlaq Awan
12 [GO] 2023―Dec―21 Changes in prescribing of psychotropic vs some physical health medication in primary care through the COVID-19 pandemic in England: a national-level survey Unaiza Waheed, Mike Stedman, Mark Davies, Emma Solomon, David Taylor, Adrian Heald, et al. (+2)
13 [GO] 2023―Dec―11 Correction: mRNA vaccine development during the COVID-19 pandemic: a retrospective review from the perspective of the Swiss affiliate of a global biopharmaceutical company Tim Killeen, Vanessa Kermer, Rahel Troxler Saxer
14 [GO] 2023―Nov―28 Reliability and validity of the Malay version of the drive-thru community pharmacy service questionnaire and the Malaysian public’s awareness, attitudes, and perceptions of drive-thru community pharmacy during COVID-19 Bayan F. Ababneh, Siew Chin Ong, Louai Alsaloumi, Hisham Z. Aljamal, Rabia Hussain
15 [GO] 2023―Nov―28 Behaviour and associated determinants of COVID-19 vaccine acceptance and advocacy: a nationwide survey of pharmacy professionals in Qatar Moza Al Hail, Pallivalapila Abdulrouf, Derek Stewart, Wessam Elkassem, Rajvir Singh, Rasha Al Enany, et al. (+3)
16 [GO] 2023―Nov―27 mRNA vaccine development during the COVID-19 pandemic: a retrospective review from the perspective of the Swiss affiliate of a global biopharmaceutical company Tim Killeen, Vanessa Kermer, Rahel Troxler Saxer
17 [GO] 2023―Nov―27 Evaluation of outpatient prescription patterns of COVID-19 drugs in Iran: comparison of real practice with local therapeutic recommendations Amir H. Zargarzadeh, Zoha Abdi, Sarah Mousavi
18 [GO] 2023―Nov―20 Does tocilizumab have an effect on the clinical outcomes in COVID-19 patients? A meta-analysis of randomized control trials Faezeh Ghaempanah, Maziar Nikouei, Mojtaba Cheraghi, Arman Jahangiri, Yousef Moradi
19 [GO] 2023―Nov―13 Examining corruption risks in the procurement and distribution of COVID-19 vaccines in select states in Nigeria Obinna Onwujekwe, Charles Orjiakor, Pamela Ogbozor, Ifunanya Agu, Prince Agwu, Tom Wright, et al. (+2)
20 [GO] 2023―Oct―25 Medication management of COVID-19 patients during transition to virtual models of care: a qualitative study H. Laetitia Hattingh, Catherine Edmunds, Brigid M. Gillespie
21 [GO] 2023―Sep―22 Impact of COVID-19 on the supply chain of essential health commodities: a mixed method study, in Dar es Salaam, Tanzania Pius Ipagala, Eulambius M. Mlugu, Rogers Mwakalukwa, Godeliver A. Kagashe
22 [GO] 2023―Aug―10 A qualitative assessment of the adverse effects associated with COVID-19 vaccines: a study from Jordan Rawan Al-Bawab, Rana Abu-Farha, Faris El-Dahiyat, Razan I. Nassar, Mohammed Zawiah
23 [GO] 2023―Jul―10 Experience and attitudes of pharmacists towards challenges and adaptive measures to new norm in ward pharmacy practice during the COVID-19 pandemic Chew Beng Ng, You Leng Tan, Ros Sakinah Kamaludin, Chee Tao Chang, Chii-Chii Chew, Wai Keng Foong, et al. (+3)
24 [GO] 2023―Jun―13 Following the COVID-19 playbook and battling another infodemic: conspiracy beliefs around human monkeypox among the Lebanese population Dalal Youssef, Lea Bleibel, Edmond Abboud
25 [GO] 2023―May―17 The impact of COVID-19 on electronic repeat dispensing (eRD) in general practice Raman Sharma, Farideh A. Javid
26 [GO] 2023―Apr―05 Attitudes and concerns regarding booster dose of COVID-19 vaccine among Egyptian patients with autoimmune and rheumatic diseases: a cross-sectional survey study Samar Tharwat, Elshimaa Saad Eleraky, Toqa Adel, Mohammed Kamal Nassar, Marwa Saleh
27 [GO] 2023―Mar―26 Qualitative exploration of perspectives of the pharmacists working in public-sector hospitals during COVID-19 pandemic Sitaram Khadka, Mohammad Saleem, Muhammad Usman, Furqan K. Hashmi, Fatima Tariq, Warda Zaheer, et al. (+4)
28 [GO] 2023―Mar―22 Continuity of CVD treatment during the COVID-19 pandemic: evidence from East Java, Indonesia Aksari Dewi, Elizabeth Pisani, Bachtiar Rifai Pratita Ihsan, Ayuk Lawuningtyas Hariadini, Anushka Patel, Anna Palagyi, et al. (+2)
29 [GO] 2023―Mar―09 COVID-19 and diabetes in 2020: a systematic review Farideh A. Javid, Fadi Abdul Waheed, Nisa Zainab, Hamza Khan, Ibrahim Amin, Ammar Bham, et al. (+3)
30 [GO] 2023―Mar―03 Secondary bacterial infection caused by ST16 NDM-1 and OXA-48-producing colistin and carbapenem-resistant Klebsiella pneumoniae treated with tigecycline in a pregnant woman with COVID-19 Samaneh Pourajam, Azam Zafarbakhsh, Majid Hosseinzadeh, Mohammad Shirzadi, Mansour Siavash, Hamid Solgi
31 [GO] 2023―Mar―02 Impact of COVID-19 pandemic on the availability of maternal and child health products and childhood vaccines Tsegaye Melaku, Desta Assefa, Fanta Gashe, Mestawet Getachew, Temesgen Kabeta, Zeleke Mekonnen
32 [GO] 2023―Mar―02 Hospital pharmacy response to the COVID-19 pandemic: experience from a regional referral center in the United Arab Emirates Muhammad Hammad, Mohammad Mousa Tashtoush, El Mutasim Ahmed El Faki, Marwa Yousif Hajaj, Saima Saeed Ahmed, Amal Ahmed Darwish
33 [GO] 2023―Feb―24 Telepharmacy during home isolation: drug-related problems and pharmaceutical care in COVID-19 patients receiving antiviral therapy in Thailand Worapong Sungsana, Chotirat Nakaranurack, Benjabhorn Weeraphon, Watsa Charoenwaiyachet, Supparat Chanprasert, Pattama Torvorapanit, et al. (+2)
34 [GO] 2023―Feb―24 A 1-year analysis of adverse events following COVID-19 vaccination in Lebanon: a retrospective study Abeer Zeitoun, Souheil Hallit, Sirine Chehade, Aya Ibrahim, Maya Helali, Carla Allam, Rita Karam
35 [GO] 2023―Jan―27 Community pharmacists’ perceptions and experiences of stress during COVID-19 Loreta Tobia, Mario Muselli, Fabio De Luca, Vincenza Cofini, Giada Mastrangeli, Leila Fabiani, Stefano Necozione
36 [GO] 2023―Jan―17 Leveraging electronic logistics management information systems to enhance and optimize supply chain response during public health emergencies: lessons from COVID-19 response in Uganda John Hans Wasswa, Henry Oundo, Martin Olowo Oteba, Henry Komakech, Irene Ochola, Sheila Mwebaze, et al. (+5)
37 [GO] 2023―Jan―16 Effectiveness of different treatment regimens on patients with COVID-19, hospitalized in Sanandaj hospitals: a retrospective cohort study Jalal Asadi, Mohammad Aziz Rasouli, Ebrahim Ghaderi, Daem Roshani, Behzad Mohsenpour, Yousef Moradi, Ghobad Moradi
38 [GO] 2023―Jan―12 Polypharmacy and potentially inappropriate medications among hospitalized older adults with COVID-19 in Malaysian tertiary hospitals Chee-Tao Chang, Siti Mallissa Mohd Shariff, Nur Suriana Abu Bakar, Nasiha Sufina Ramzuzzaman, Chun Kiat Lim, Eddy Yew Joe Lim, et al. (+11)
39 [GO] 2022―Dec―16 Prevalence and correlates of burnout among Lebanese health care workers during the COVID-19 pandemic: a national cross-sectional survey Dalal Youssef, Edmond Abboud, Linda Abou-Abbas, Hamad Hassan, Janet Youssef
40 [GO] 2022―Nov―23 Changes in drug demand when a pandemic coincides with other outbreaks in a war zone country: a cross-sectional pilot study Ebtesam A. Saleh, Randa N. Haddadin, Bassam Saleh, Eman Elayeh
41 [GO] 2022―Nov―04 The effect of COVID-19 home quarantine on the psychological state of pharmacy students: a cross-sectional study Asmaa S. Mohamed, Ahmed A. Abdelrahman, Hosam M. Ahmad, Omar R. Abdel Aziz, Yasmeen S. Mesameh, Soad A. Mohamad
42 [GO] 2022―Oct―30 Public views of community pharmacy services during the COVID-19 pandemic: a national survey Alein W. Bou-Saba, Kassem M. Kassak, Pascale R. Salameh
43 [GO] 2022―Oct―23 Managing nirmatrelvir/ritonavir during COVID-19: pharmacists’ experiences from the Perak state of Malaysia Chee Tao Chang, Su Yin Ong, Xin Jie Lim, Lan Sim Chew, Philip Rajan
44 [GO] 2022―Oct―18 Mental health outcomes and workplace quality of life among South African pharmacists during the COVID-19 pandemic: a cross-sectional study Sherishka Dhindayal, Marothi P. Letsoalo, Tanuja N. Gengiah
45 [GO] 2022―Oct―15 Vaccination process evaluation at COVID-19 vaccination centers in Lebanon: a national study Abeer Zeitoun, Souheil Hallit, Maya Helali, Sirine Chehade, Carla Allam, Aya Ibrahim, et al. (+2)
46 [GO] 2022―Oct―06 Parental COVID-19 vaccination hesitancy among parents of children aged 5-18 years in Thailand: a cross-sectional survey study Pantira Parinyarux, Kanokkarn Sunkonkit, Kitiyot Yotsombut
47 [GO] 2022―Aug―30 Practice of non-pharmaceutical interventions against COVID-19 and reduction of the risk of influenza-like illness: a cross-sectional population-based study Dalal Youssef, Ola Issa, Maysaloun Kanso, Janet Youssef, Linda Abou-Abbas, Edmond Abboud
48 [GO] 2022―Aug―19 State capture through indemnification demands? Effects on equity in the global distribution of COVID-19 vaccines Ariel Gorodensky, Jillian C. Kohler
49 [GO] 2022―Aug―17 An analysis of COVID-19 information sources Belachew Umeta, Temesgen Mulugeta, Girma Mamo, Sintayehu Alemu, Nimona Berhanu, Gudina Milkessa, et al. (+2)
50 [GO] 2022―Jul―29 The need for a functional pharmaceutical industry in Sierra Leone: lessons from the COVID-19 pandemic Eugene Conteh, Melody Okereke, Foday Umaro Turay, Alhaji Sununu Bah, Abdulwasiu Muhsinah
51 [GO] 2022―Jun―16 Contributions and challenges of community pharmacists during the COVID-19 pandemic: a qualitative study Claire Durand, Eric Douriez, Aude Chappuis, Frédérique Poulain, Yazdan Yazdanpanah, Sylvie Lariven, et al. (+2)
52 [GO] 2022―May―02 Prevalence, pattern and predictors of self-medication for COVID-19 among residents in Umuahia, Abia State, Southeast Nigeria: policy and public health implications Chidinma Ihuoma Amuzie, Kalu Ulu Kalu, Michael Izuka, Uche Ngozi Nwamoh, Uloaku Emma-Ukaegbu, Franklin Odini, et al. (+3)
53 [GO] 2022―Apr―26 COVID-19 vaccines: awareness, attitude and acceptance among undergraduate University students Firew Asres, Belachew Umeta
54 [GO] 2022―Apr―01 Redistribution of critical drugs in shortage during the first wave of COVID-19 in France: from operating theaters to intensive care units Claire Chapuis, Rémy Collomp, Laura Albaladejo, Hugo Terrisse, Stéphane Honoré, Jean-Luc Bosson, et al. (+2)
55 [GO] 2022―Mar―28 Assessing public knowledge, attitudes and determinants of third COVID-19 vaccine booster dose acceptance: current scenario and future perspectives Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, Faris El-Dahiyat, Maimona Jairoun, Moyad Shahwan, Mena Al Ani, et al. (+2)
56 [GO] 2022―Mar―17 Feeling the burn in the era of COVID-19: cross-cultural adaptation and validation of the Arabic version of the Copenhagen Burnout Inventory among community pharmacists Dalal Youssef, Linda Abou-Abbas, Janet Youssef
57 [GO] 2022―Mar―02 Management of COVID-19 vaccines cold chain logistics: a scoping review Mathumalar Loganathan Fahrni, Intan An-Nisaa’ Ismail, Dalia Mohammed Refi, Ahmad Almeman, Norliana Che Yaakob, Kamaliah Md Saman, et al. (+3)
58 [GO] 2022―Jan―11 The landscape of antibiotic usage among COVID-19 patients in the early phase of pandemic: a Malaysian national perspective Izzati-Nadhirah Mohamad, Calvin Ke-Wen Wong, Chii-Chii Chew, E-Li Leong, Biing-Horng Lee, Cheng-Keat Moh, et al. (+3)
59 [GO] 2022―Jan―11 Assessment of COVID-19 vaccines acceptance in the Lebanese population: a national cross-sectional study Philippe Hanna, Aline Issa, Ziad Noujeim, Mira Hleyhel, Nadine Saleh
60 [GO] 2021―Dec―24 Prevalence and risk factors of burnout among Lebanese community pharmacists in the era of COVID-19 pandemic: results from the first national cross-sectional survey Dalal Youssef, Janet Youssef, Hamad Hassan, Linda Abou-Abbas
61 [GO] 2021―Dec―24 Marketing authorization of COVID-19 vaccines across UK, EU, and the US: fact-checking and the implications for future research Nasir Abbas, Zaheer-Ud-Din Babar
62 [GO] 2021―Dec―02 Knowledge and perceptions of pharmacists’ readiness during coronavirus pandemic: the case of United Arab Emirates Iman A. Basheti, Nizar M. Mhaidat, Sayer Al-Azzam, Rajaa Alqudah, Razan Nassar, Hamzah Alzubaidi, et al. (+2)
63 [GO] 2021―Nov―04 COVID-19’s impact on neglected pharmaceutical staff: wake-up call for needed research Richard Antony Powell, Shivali Lakhani, Marsha Alter, Steven Guan, Jehanita Jesuthasan, Dasha Nicholls
64 [GO] 2021―Oct―25 Incidence of adverse reaction of drugs used in COVID-19 management: a retrospective, observational study Jia Yin Lee, Abby Shoon Yeun Ang, Nurdalila Mohd Ali, Li Min Ang, Azura Omar
65 [GO] 2021―Sep―29 Impact of the first phase of COVID-19 pandemic on childhood routine immunisation services in Nepal: a qualitative study on the perspectives of service providers and users Asmita Priyadarshini Khatiwada, Smriti Maskey, Nistha Shrestha, Sunil Shrestha, Saval Khanal, Bhuvan KC, Vibhu Paudyal
66 [GO] 2021―Aug―06 Young hospital pharmacists’ job stress and career prospects amidst the COVID-19 pandemic in China Jiahao Wu, Jian Cai, Ming Fang, Yan Wang, Feng Xu
67 [GO] 2021―Jul―18 Pharmacy preparedness in handling COVID-19 pandemic: a sharing experience from a Malaysian tertiary hospital Kah Shuen Thong, Manimegahlai Selvaratanam, Chiew Ping Tan, Meng Fei Cheah, Hoey Lin Oh, Pooi Mun Lee, et al. (+3)
68 [GO] 2021―Jun―11 A cross-sectional survey on community pharmacists readiness to fight COVID-19 in a developing country: knowledge, attitude, and practice in Lebanon Rony M. Zeenny, Ahmad Dimassi, Hala Sacre, Ghada El Khoury, Aline Hajj, Rita Farah, et al. (+5)
69 [GO] 2021―May―11 Correction to: Online medication purchasing during the Covid-19 pandemic: a pilot study from the United Arab Emirates Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, Naseem Mohammed Abdulla, Faris El-Dahiyat, Maimona Jairoun, Saleh Karamah AL-Tamimi, Zaheer-Ud-Din Babar
70 [GO] 2021―May―10 Assessments of the quality systems of pharmaceutical distributors: a remote approach to be applied in times of COVID-19 and beyond Anthony Bourasseau, Laurine Lavergne, Raffaella Ravinetto
71 [GO] 2021―May―03 Public and private sectors collective response to combat COVID-19 in Malaysia Ching Siang Tan, Saim Lokman, Yao Rao, Szu Hua Kok, Long Chiau Ming
72 [GO] 2021―May―03 Adequacy of alcohol-based handrub solution production practice in response to COVID-19 in public hospitals found in Addis Ababa, Ethiopia: a multicentered cross-sectional study Muluken Nigatu Selam, Regasa Bayisa, Andualem Ababu, Mahdi Abdella, Edessa Diriba, Minychel Wale, Assefa Mulu Baye
73 [GO] 2021―Apr―30 Online medication purchasing during the Covid-19 pandemic: potential risks to patient safety and the urgent need to develop more rigorous controls for purchasing online medications, a pilot study from the United Arab Emirates Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, Naseem Mohammed Abdulla, Faris El-Dahiyat, Maimona Jairoun, Saleh Karamah AL-Tamimi, Zaheer-Ud-Din Babar
74 [GO] 2021―Feb―24 Perceived barriers and facilitators to uptake of non-traditional roles by pharmacists in Saudi Arabia and implications for COVID-19 pandemic and beyond: a qualitative study using Theoretical Domain Framework Eeman Mohammed, Saval Khanal, Zahraa Jalal, Ejaz Cheema, Mohammed H. Abutaleb, Vibhu Paudyal
75 [GO] 2021―Feb―10 Universal health coverage and COVID-19: recent developments and implications Rabia Hussain, Sara Arif
76 [GO] 2021―Jan―22 Drug supply shortage in Nigeria during COVID-19: efforts and challenges Edward Faiva, Hashim Talib Hashim, Mustafa Ahmed Ramadhan, Shingin Kovona Musa, John Bchara, Yahya Dheyaa Tuama, et al. (+5)
77 [GO] 2021―Jan―20 Drug supply situation in Rwanda during COVID-19: issues, efforts and challenges Theogene Uwizeyimana, Hashim Talib Hashim, Jean Damascene Kabakambira, Jean Claude Mujyarugamba, Jackson Dushime, Blaise Ntacyabukura, et al. (+3)
78 [GO] 2021―Jan―06 New missions of a hospital pharmaceutical technology unit during the COVID-19 pandemic Alexandra Garnier, Ludivine Falaschi, Pascal Bonnabry, Lucie Bouchoud
79 [GO] 2021―Jan―04 Medicines dispensing practice during the era of COVID-19 pandemic: a commentary Gemmechu Hasen, Rashed Edris, Gadisa Chala, Yesuneh Tefera, Hawi Hussen, Tamirat Tekassa, Sultan Suleman
80 [GO] 2020―Dec―09 Pharmacy response to COVID-19: lessons learnt from Canada Ali Elbeddini, Amy Botross, Rachel Gerochi, Mohamed Gazarin, Ahmed Elshahawi
81 [GO] 2020―Nov―02 Pharmacy services during COVID-19 pandemic: experience from a tertiary care teaching hospital in Pakistan Kashif Hussain, Gul Ambreen, Mehreen Muzammil, Syed Shamim Raza, Umer Ali
82 [GO] 2020―Oct―21 Needs assessment and impact of COVID-19 on pharmacy professionals in 31 commonwealth countries Diane Ashiru-Oredope, Amy Hai Yan Chan, Omotayo Olaoye, Victoria Rutter, Zaheer-Ud-Din Babar
83 [GO] 2020―Sep―22 Pharmacists’ perceived barriers towards delivering their emergency roles during the COVID-19 pandemic and perceived policymakers’ responsibilities Iman A. Basheti, Razan Nassar, Muna Barakat, Rajaa Alqudah, Rana Abu Farha, Tareq Muqatash, et al. (+2)
84 [GO] 2020―Sep―21 Understanding the factors influencing healthcare providers’ burnout during the outbreak of COVID-19 in Jordanian hospitals Abdullah Algunmeeyn, Faris El-Dahiyat, Mohammad Mitib Altakhineh, Mohammad Azab, Zaheer-Ud-Din Babar
85 [GO] 2020―Sep―21 The use of remdesivir outside of clinical trials during the COVID-19 pandemic Vesa Halimi, Armond Daci, Nevenka Ridova, Irina Panovska-Stavridis, Milena Stevanovic, Venko Filipce, et al. (+2)
86 [GO] 2020―Sep―17 Assessing knowledge, attitude, practice, and preparedness of hospital pharmacists in Lebanon towards COVID-19 pandemic: a cross-sectional study Rony M. Zeenny, Elsy Ramia, Youssef Akiki, Souheil Hallit, Pascale Salameh
87 [GO] 2020―Sep―11 The Urgent Need for Transparent and Accountable Procurement of Medicine and Medical Supplies in Times of COVID-19 Pandemic Jillian Clare Kohler, Tom Wright
88 [GO] 2020―Jul―24 COVID-19 therapeutics: how to sow confusion and break public trust during international public health emergencies Jerome Amir Singh, Rafaella Ravinetto
89 [GO] 2020―Jul―22 Mental health issues impacting pharmacists during COVID-19 Ali Elbeddini, Cindy Xin Wen, Yasamin Tayefehchamani, Anthony To
90 [GO] 2020―Jul―17 Unrealized potential of drug repositioning in europe during COVID-19 and beyond: a physcian’s perspective A. B. Bayoumy, N. K. H. de Boer, A. R. Ansari, F. Crouwel, C. J. J. Mulder
91 [GO] 2020―Jul―15 Risks to the community pharmacists and pharmacy personnel during COVID-19 pandemic: perspectives from a low-income country B. Dzingirai, C. M. J. Matyanga, T. Mudzviti, M. Siyawamwaya, D. Tagwireyi
92 [GO] 2020―Jul―15 Identification of the awareness level by the public of Arab countries toward COVID-19: cross-sectional study following an outbreak Ruwidah Bonyan, Aseel Fuad Al-Karasneh, Faris El-Dahiyat, Ammar Abdulrahman Jairoun
93 [GO] 2020―Jul―11 Saudi Arabia, pharmacists and COVID-19 pandemic Ajaz Ahmad, Khalid M. Alkharfy, Ziyad Alrabiah, Abdulaziz Alhossan
94 [GO] 2020―Jun―19 Pharmacists and COVID-19 Ali Elbeddini, Thulasika Prabaharan, Sarah Almasalkhi, Cindy Tran
95 [GO] 2020―Jun―15 COVID-19 and community pharmacy services in Pakistan: challenges, barriers and solution for progress Muhammad Atif, Iram Malik
96 [GO] 2020―Jun―11 Correction to: Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety Ali Elbeddini, Aniko Yeats, Stephanie Lee
97 [GO] 2020―May―27 Pharmacist intervention amid the coronavirus disease 2019 (COVID-19) pandemic: from direct patient care to telemedicine Ali Elbeddini, Aniko Yeats
98 [GO] 2020―May―25 Pharmacists reinventing their roles to effectively respond to COVID-19: a global report from the international pharmacists for anticoagulation care taskforce (iPACT) Filipa Alves da Costa, Vivian Lee, Silvana Nair Leite, Maria Dolores Murillo, Tom Menge, Sotiris Antoniou
99 [GO] 2020―May―20 Sterilization plan of the used metered dose inhalers (MDI) to avoid wastage amid COVID-19 pandemic drug shortage Ali Elbeddini
100 [GO] 2020―May―18 Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety Ali Elbeddini, Aniko Yeats, Stephanie Lee
101 [GO] 2020―May―16 Current regulatory approaches for accessing potential COVID-19 therapies Vesa Halimi, Armond Daci, Simona Stojanovska, Irina Panovska-Stavridis, Milena Stevanovic, Venko Filipce, Aleksandra Grozdanova
102 [GO] 2020―May―15 A step towards gender equity to strengthen the pharmaceutical workforce during COVID-19 Nadia Bukhari, Mehr Manzoor, Huma Rasheed, Bismah Nayyer, Madeeha Malik, Zaheer-Ud-Din Babar
103 [GO] 2020―May―13 Together we unite: the role of the Commonwealth in achieving universal health coverage through pharmaceutical care amidst the COVID-19 pandemic Amy Hai Yan Chan, Victoria Rutter, Diane Ashiru-Oredope, Chloe Tuck, Zaheer-Ud-Din Babar
104 [GO] 2020―Apr―20 Pharmacists at the frontline beating the COVID-19 pandemic Nadia Bukhari, Huma Rasheed, Bismah Nayyer, Zaheer-Ud-Din Babar
 [1] 

104 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec